Clinical Trials Browser

Unknown × avelumab × Tumor-Agnostic × Clear all

NCT05289856 2024-03-07

Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)

Phase 2 Unknown

Neoplasms

NCT04698213 2021-01-06

TIDE-A

Phase 2 Unknown

Carcinoma, Neoplasm Metastasis